Bill & Melinda Gates FoundationGlobal Grand Challenges
  • Grant Opportunities
  • Challenges
  • Awards
  • Champions
  • Partnerships
  • News
  • About

Latency: A Biomarker Discovery Pipeline

Amalio Telenti of the Institute of Microbiology in Switzerland proposes to identify biomarkers specific to HIV latency using high-throughput screening of RNA sequences and a customized screening tool for validating HIV positive individuals. If successful, the biomarkers could be used in the study of HIV latency reservoirs and aid eradication efforts.

More information about Design New Approaches to Cure HIV Infection (Round 6)